Comparison of first-tier cell-free DNA screening for common aneuploidies with conventional publically funded screening.

cfDNA screening has the potential to be a highly effective first-tier screening approach leading to a significant reduction of invasive diagnostic procedures. For women with a negative cfDNA screening result, NT measurement has limited clinical utility.